ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445,908 | +19.1% | 907 | -5.6% | 0.02% | +25.0% |
| Q2 2023 | $374,531 | -12.2% | 961 | -16.1% | 0.02% | -23.1% |
| Q1 2023 | $426,604 | +6.5% | 1,145 | +8.3% | 0.03% | 0.0% |
| Q4 2022 | $400,423 | -44.6% | 1,057 | -48.4% | 0.03% | -50.0% |
| Q3 2022 | $723,000 | -16.2% | 2,049 | -10.1% | 0.05% | -5.5% |
| Q2 2022 | $863,000 | +3.6% | 2,279 | -13.7% | 0.06% | +57.1% |
| Q1 2022 | $833,000 | +85.1% | 2,641 | +105.4% | 0.04% | +133.3% |
| Q4 2021 | $450,000 | +43.3% | 1,286 | +23.5% | 0.02% | +36.4% |
| Q3 2021 | $314,000 | +4.7% | 1,041 | +4.4% | 0.01% | +10.0% |
| Q2 2021 | $300,000 | +12.4% | 997 | +2.7% | 0.01% | 0.0% |
| Q1 2021 | $267,000 | -2.9% | 971 | +3.7% | 0.01% | -16.7% |
| Q4 2020 | $275,000 | – | 936 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |